ConductScience.org, home

Paper422252

[Current chemotherapy of infections caused by Pseudomonas aeruginosa (author's transl)].

Bauernfeind A and 2 others. Infection, 1979. Cited by 5 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. [Current chemotherapy of infections caused by Pseudomonas aeruginosa (author's transl)]. Papers, record 422252. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/422252

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
[Current chemotherapy of infections caused by Pseudomonas aeruginosa (author's transl)].
PubMed
Journal
Infection
PubMed
Year
1979
PubMed
Publication types
English Abstract, Journal Article
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
0.42
iCite
Revised in PubMed
2019-08-27
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bauernfeind AA
2Petermüller CC
3Dietzel MM

Source PubMed

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CarbenicillinMajor topic
PenicillinsMajor topic
Pseudomonas InfectionsMajor topic
TicarcillinMajor topic
Aminoglycosides
Humans
Microbial Sensitivity Tests
Penicillin Resistance

Source PubMed

References21

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
118,083Azlocillin: in vitro studies of a new semisynthetic penicillin.Antimicrob Agents Chemother1977https://conductscience.org/library/papers/18083PubMed
2977,133[Pharmacokinetics of azlocillin, a new semisynthetic, wide-spectrum antibiotic (author's transl)].Infection1976https://conductscience.org/library/papers/977133PubMed
3795,372Ticarcillin in combination with cephalothin or gentamicin as empiric antibiotic therapy in granulocytopenic cancer patients.Antimicrob Agents Chemother1976https://conductscience.org/library/papers/795372PubMed
4412,776[Bacteria and resistance patterns in bacteriuria of hospitalized patients (author's transl)].Immun Infekt1977https://conductscience.org/library/papers/412776PubMed
54,218,163[Ticarcillin: in-vitro activity and pharmacokinetics (author's transl)].Dtsch Med Wochenschr1974https://conductscience.org/library/papers/4218163PubMed
64,974,900[Studies on Pseudomonas aeruginosa in surface water. I. Sources].Arch Hyg Bakteriol1968https://conductscience.org/library/papers/4974900PubMed
74,210,892Preliminary clinical experience with ticarcillin (BRL 2288) in 101 patients treated for severe respiratory infections.Chemotherapy1974https://conductscience.org/library/papers/4210892PubMed
8984,764Comparative activity in vitro of ticarcillin, BL-P1654, and carbenicillin.Antimicrob Agents Chemother1976https://conductscience.org/library/papers/984764PubMed
94,208,532Activity of carbenicillin and ticarcillin against Pseudomonas aeruginosa compared by paired in vitro tests.Infection1974https://conductscience.org/library/papers/4208532PubMed
10418,604[Modified procedure for pyocin typing of Pseudomonas aeruginosa (author's transl)].Zentralbl Bakteriol Orig A1978https://conductscience.org/library/papers/418604PubMed
116,069,557New semi-synthetic penicillin active against Pseudomonas pyocyanea.Nature1967https://conductscience.org/library/papers/6069557PubMed
124,995,575The fate of ingested Pseudomonas aeruginosa in normal persons.J Med Microbiol1969https://conductscience.org/library/papers/4995575PubMed
135,000,263-carboxy-3-thienylmethylpenicillin (BRL 2288), a new semisynthetic penicillin: in vitro evaluation.Antimicrob Agents Chemother (Bethesda)1970https://conductscience.org/library/papers/5000263PubMed
144,162,795Faecal carriage of Pseudomonas aeruginosa in hospital patients. Possible spread from patient to patient.Lancet1966https://conductscience.org/library/papers/4162795PubMed
164,210,893Clinical and laboratory investigations on ticarcillin, an anti-pseudomonal antibiotic.Chemotherapy1974https://conductscience.org/library/papers/4210893PubMed
17418,741Suggested procedure allowing use of plastic petri dishes in bacteriocin typing.Appl Environ Microbiol1978https://conductscience.org/library/papers/418741PubMed
18334,673[Azlocillin and mezlocillin: two new semisynthetic acylureido-penicillins (author's transl)].Infection1977https://conductscience.org/library/papers/334673PubMed
19410,735[Azlocillin--a new penicillin against Pseudomonas aeruginosa and other gram-negative bacteria].Infection1977https://conductscience.org/library/papers/410735PubMed
204,990,646Observations on the intestinal carriage of Pseudomonas aeruginosa.J Med Microbiol1970https://conductscience.org/library/papers/4990646PubMed
21825,582Ticarcillin for treatment of serious infections with gram-negative bacteria.J Infect Dis1976https://conductscience.org/library/papers/825582PubMed

See all 21 references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn Papers
6,286,502[Therapy with cefotaxime-cefotaxime/ticarcillin for bronchopulmonary infections in patients under intensive care. (author's transl)].Infection1982https://conductscience.org/library/papers/6286502

Source PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/422252

GET https://conductscience.org/api/papers/v1/422252/references?page=2